These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22207740)

  • 1. Complete genome sequences of three Pseudomonas aeruginosa isolates with phenotypes of polymyxin B adaptation and inducible resistance.
    Boyle B; Fernandez L; Laroche J; Kukavica-Ibrulj I; Mendes CM; Hancock RW; Levesque RC
    J Bacteriol; 2012 Jan; 194(2):529-30. PubMed ID: 22207740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
    Abraham N; Kwon DH
    FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
    Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
    J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
    Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
    Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL
    J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutators.
    Bulman ZP; Sutton MD; Ly NS; Bulitta JB; Holden PN; Nation RL; Li J; Tsuji BT
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4343-6. PubMed ID: 25918151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
    Barrow K; Kwon DH
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.
    Gilleland HE; Farley LB
    Can J Microbiol; 1982 Jul; 28(7):830-40. PubMed ID: 6293694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
    Landman D; Bratu S; Alam M; Quale J
    J Antimicrob Chemother; 2005 Jun; 55(6):954-7. PubMed ID: 15883174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the polymyxin B resistome of Pseudomonas aeruginosa.
    Fernández L; Alvarez-Ortega C; Wiegand I; Olivares J; Kocíncová D; Lam JS; Martínez JL; Hancock RE
    Antimicrob Agents Chemother; 2013 Jan; 57(1):110-9. PubMed ID: 23070157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
    Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin B Etest
    Kulengowski B; Ribes JA; Burgess DS
    Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biofilm production on polymyxin B susceptibility among Pseudomonas aeruginosa clinical isolates.
    da Silva Carvalho T; Rodrigues Perez LR
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):739-740. PubMed ID: 31006400
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
    Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates.
    Wilhelm CM; Nunes LS; Martins AF; Barth AL
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):152-154. PubMed ID: 29891185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B.
    Bratu S; Quale J; Cebular S; Heddurshetti R; Landman D
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):196-201. PubMed ID: 15772821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Miyajima Y; Hiramatsu K; Mizukami E; Morinaga R; Ishii H; Shirai R; Kishi K; Tokimatsu I; Saikawa T; Kadota J
    Int J Antimicrob Agents; 2008 Nov; 32(5):437-40. PubMed ID: 18715759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.